Health Innovation Manchester (HInM) has signed a Memorandum of Understanding (MoU) with the Government of Telangana in India, one of Asia’s leading life science hubs.
The MoU was signed on Tuesday, 25 February in Hyderabad, the capital of Telangana, at BioAsia, an internationally renowned life science and health-tech event. It represents a joint commitment to foster economic growth and innovation to address shared healthcare challenges.
By strengthening ties, both regions aim to fulfil their longer-term ambitions of developing cutting-edge products, treatments, diagnostics, medtech solutions, and digital tools to enhance the experience and outcomes of patients.
This new alliance will strengthen bilateral ties and put in place a framework to foster healthcare innovation and mobilise a pipeline of new innovations. It will facilitate the exchange of knowledge and resources, creating an opportunity to harness research and data analysis capabilities that could support life-changing clinical trials and real-world studies.
Telangana is at the forefront of innovation, creating an environment where research and development centres, manufacturers, training institutions and testing laboratories can all flourish. It hosts over 100 pharmaceutical and biotech companies, including 4 of the top global pharmaceutical firms and over 20 life science and MedTech incubators and is home to Technology Hub (T-Hub) the world’s largest innovation ecosystem under one roof. under one roof.
This agreement is HInM’s first formal international partnership with an overseas government state. It aligns to a broader strategy led by HInM and MIDAS, (Greater Manchester’s inward investment agency) to position Greater Manchester as a global learning market capable of implementing novel innovations across a large population and attracting economic growth.
Andrea Winders, Head of Inward Investment for Life Sciences at MIDAS, Manchester’s Inward Investment Agency, said: “The signing of this agreement between the Government of Telangana and Health Innovation Manchester represents a considerable step in fostering healthcare innovation between Greater Manchester and Telangana and is a significant milestone for our life sciences sector.
“MIDAS is proud to support the collaboration which will create new opportunities for knowledge exchange and joint development of solutions to support the life science and healthcare sector in both regions.”
Professor Ben Bridgewater, Chief Executive at HInM commented: “I am thrilled that we are building stronger ties between Greater Manchester and India. By working together and combining our expertise, I believe we will be in a stronger position to make significant progress in improving local healthcare to give patients the best possible outcome.”
Oliver Barnes, Programme Director at HlnM and the driving force behind the agreement, said: “We are eager to advance our understanding of new technology, therapies and ways of working being delivered elsewhere. This will benefit healthcare in both regions and help us establish GM as a global learning market able to provide accelerated access to novel innovations at scale.”
Jayesh Ranjan, Special Chief Secretary of Information Technology, Electronics and Communications (ITE&C) and Industries and Commerce Departments of the Government of Telangana said: “We are pleased to establish this collaboration with Health Innovation Manchester, aligning with Telangana’s vision of building global partnerships to advance healthcare innovation. The MoU signed at BioAsia, represents an important step toward exchanging knowledge and co-developing cutting-edge solutions. Telangana continues to be a key player in the global life sciences industry, with a thriving ecosystem of research institutions, biotech startups, and leading pharmaceutical companies. This collaboration will strengthen both regions’ capabilities and create new opportunities for growth and development.”
